Literature DB >> 1801639

Drug resistance of Pseudomonas aeruginosa with special reference to new quinolones.

S Iyobe1, K Hirai, H Hashimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1801639     DOI： 10.1159/000420316

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN： 0066-4758


× No keyword cloud information.
  5 in total

Review 1.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  Conservation of the multidrug resistance efflux gene oprM in Pseudomonas aeruginosa.

Authors:  N Bianco; S Neshat; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

3.  Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.

Authors:  T Yoshida; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

4.  Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa.

Authors:  E B Jakics; S Iyobe; K Hirai; H Fukuda; H Hashimoto
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

5.  Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.

Authors:  A Kitamura; K Hoshino; Y Kimura; I Hayakawa; K Sato
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.